European Hematology Association - 31st Congress, 2026 (EHA) 11 - 14 June 2026

Etavopivat reduces transfusion requirements in adults and adolescents with transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study

Authors :

Ashutosh Lal¹; Saranya Veluswamy²; Melanie Kirby-Allen³; Yves Pastore⁴; Janet Kwiatkowski⁵; Leila Jerome Clay⁶; Olga Polyanskaya⁷; Navid Nedjatian⁸; Ali T. Taher⁹

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Thalassemia

Congress oral presentation

Etavopivat

Search Science Hub

Are you a healthcare professional?

Etavopivat reduces transfusion requirements in adults and adolescents with transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study